BioSpace News Archive

Repro Med Systems, Inc. dba KORU Medical Systems announced that it will release its financial results for the fourth quarter and full year ended December 31, 2019 after the close of the financial markets on Tuesday, February 25, 2020.

Family Research Council’s Patrina Mosley, Director of Life, Culture, and Women’s Advocacy, testified before the Senate Judiciary Committee on the Born-Alive Abortion Survivors Protection Act.

The Miller Children’s Hospital Long Beach Auxiliary pledged $500,000 to support an adolescent rehabilitation gym in the future Cherese Mari Laulhere Children’s Village at MemorialCare Miller Children’s & Women’s Hospital Long Beach.

The Board of Directors of Zoetis Inc. has declared a second quarter 2020 dividend payable to holders of the company’s common stock of $0.20 per share.

As the novel coronavirus epidemic continues to evolve in China, the country has introduced controls to prevent the spread of the epidemic and reduce the risk of contagion.

Psychemedics Corporation announced fourth quarter and year-end financial results for the period ended December 31, 2019.

DermTech, Inc. announced that John Dobak, M.D., Chief Executive Officer of the Company, is scheduled to present at the following upcoming investor conferences

Dr. John R. Agar honored with Federal Services Award by the American College of Prosthodontists.

Fortress Biotech, Inc. announced that it has priced an underwritten public offering of 625,000 shares of its 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock at a price of $20 per share, with expected gross proceeds to Fortress of $12.5 million.

Feb. 11, 2020 13:30 UTC BELOIT, Wis. & SYDNEY--( BUSINESS WIRE )-- NorthStar Medical Technologies , LLC (NorthStar), a global innovator in the production and distribution of radioisotopes used for medical imaging, and Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, today announced the signing of a Letter of Intent for the commercial supply of copper-67 (Cu-67) as an active pharmaceutical ingredient for Clarity’s pipeline of